SCIMEDX PHASE II MPO IGG ANTIBODY EIA (1281)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II MPO IGG ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-myeloperoxidase (MPO) antibodies (K010289 | K010289) HIGH
Effective Date: 2001-03-28

Other General Immunology Devices:

Medical DeviceComplexity
Request Measles IgGView Complexity
Quest International Pointe Scientific Toxo IgGView Complexity
Bayer Advia 2400View Complexity
Roche Diagnostics cobas c 501 AnalyzerView Complexity
BD Multitest 6-Color TBNK Reagent with BD Trucount tubesView Complexity
Aperio ePathology eIHC IVD System – CS2View Complexity
Roche Diagnostics Hitachi 717View Complexity
Phadia 100View Complexity
Dade Behring Dimension RxLView Complexity
AESKULISA SM TEST KITView Complexity